Dr Maria Teresa Borrello is a medicinal chemist and pharmacologist, and Lecturer at the University of Sunderland. She holds an MPharm (Hons) from the University of Pavia and an MSc (Distinction) in Natural Products and Drug Discovery from University College London. She completed her PhD in Medicinal Chemistry at the University of East Anglia, focusing on small molecule inhibitors of Lysine-Specific Demethylase 1 (LSD1). Her research spans epigenetic targets, including Histone Deacetylase 6 (HDAC6), and stress-response pathways such as NUPR1, with applications in fibrosis and inflammatory skin diseases. She has held postdoctoral positions at the University of Oxford, Newcastle University, and research institutes in France. Her work emphasises translational drug discovery and innovative therapeutic strategies. She is a registered professional with the General Pharmaceutical Council (GPhC) and has received competitive research funding and fellowships supporting her work.
Dr Maria Teresa Borrello is a medicinal chemist and pharmacologist, and Lecturer at the University of Sunderland. She holds an MPharm (Hons) from the University of Pavia and an MSc (Distinction) in Natural Products and Drug Discovery from University College London. She completed her PhD in Medicinal Chemistry at the University of East Anglia, focusing on small molecule inhibitors of Lysine-Specific Demethylase 1 (LSD1). Her research spans epigenetic targets, including Histone Deacetylase 6 (HDAC6), and stress-response pathways such as NUPR1, with applications in fibrosis and inflammatory skin diseases. She has held postdoctoral positions at the University of Oxford, Newcastle University, and research institutes in France. Her work emphasises translational drug discovery and innovative therapeutic strategies. She is a registered professional with the General Pharmaceutical Council (GPhC) and has received competitive research funding and fellowships supporting her work.